Patents by Inventor Stacey V. Drabic

Stacey V. Drabic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEINS BINDING NKG2D, CD16 AND BAFF-R
    Publication number: 20240360223
    Abstract: Multispecific binding proteins that bind NKG2D receptor, CD16, and B cell-activating factor receptor (BAFF-R) are described, as well as pharmaceutical compositions and therapeutic methods of the multispecific binding proteins useful for the treatment of cancer and autoimmune inflammatory diseases.
    Type: Application
    Filed: March 29, 2024
    Publication date: October 31, 2024
    Inventors: Aaron BELLI, Ann F. CHEUNG, Stacey V. DRABIC, Daniel FALLON, Benjamin FISCHER, Asya GRINBERG, Pyae P. HEIN, Alexander IVANOV, Zong Sean JUO, Mark LEWANDOWSKI, Xinbi LI, Matthew SCHNEIDER
  • PROTEINS BINDING NKG2D, CD16 AND BAFF-R
    Publication number: 20240270861
    Abstract: Multispecific binding proteins that bind NKG2D receptor, CD16, and B cell-activating factor receptor (BAFF-R) are described, as well as pharmaceutical compositions and therapeutic methods of the multispecific binding proteins useful for the treatment of cancer and autoimmune inflammatory diseases.
    Type: Application
    Filed: March 28, 2024
    Publication date: August 15, 2024
    Inventors: Aaron BELLI, Ann F. CHEUNG, Stacey V. DRABIC, Daniel FALLON, Benjamin FISCHER, Asya GRINBERG, Pyae P. HEIN, Alexander IVANOV, Zong Sean JUO, Mark LEWANDOWSKI, Xinbi LI, Matthew SCHNEIDER
  • PROTEINS BINDING NKG2D, CD16 AND EGFR
    Publication number: 20230257467
    Abstract: Described herein are multispecific binding proteins that bind NKG2D receptor, CD 16, and EGFR, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of cancer.
    Type: Application
    Filed: August 5, 2021
    Publication date: August 17, 2023
    Inventors: Ann F. Cheung, Stacey V. Drabic, Asya Grinberg, Zong Sean Juo, Katia Liharska, Christopher Ryan Morgan, Nicolai Wagtmann
  • PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC BINDING PROTEINS THAT BIND EGFR, NKG2D, AND CD16
    Publication number: 20230250176
    Abstract: Described herein are pharmaceutical formulations comprising multi-specific binding proteins that bind to NKG2D, CD16, and epidermal growth factor receptor (EGFR); and therapeutic uses of the multi-specific binding proteins and pharmaceutical formulations thereof for treating a disease, for example, cancer, in a patient in need thereof.
    Type: Application
    Filed: February 9, 2023
    Publication date: August 10, 2023
    Inventors: Ann F. Cheung, Jean-Marie Cuillerot, Mark DeRose, Stacey V. Drabic, Asya Grinberg, Zong Sean Juo, Aaron Levin, Katia Liharska, Lynn Markowitz, Christopher Ryan Morgan, Avni Shah, Michael Shifrin, Nicolai Wagtmann